Volume 19, Issue 2 pp. 165-172
Methods
Full Access

A non-radioactive protein truncation test for the sensitive detection of all stop and frameshift mutations

Sabine Kahmann

Sabine Kahmann

Max-Planck-Institut für molekulare Physiologie, Dortmund, Germany

Search for more papers by this author
Peter Herter

Peter Herter

Max-Planck-Institut für molekulare Physiologie, Dortmund, Germany

Search for more papers by this author
Cornelius Kuhnen

Cornelius Kuhnen

Institut für Pathologie, BG-Kliniken Bergmannsheil, Ruhr-Universität Bochum, Germany

Search for more papers by this author
Klaus-Michael Müller

Klaus-Michael Müller

Institut für Pathologie, BG-Kliniken Bergmannsheil, Ruhr-Universität Bochum, Germany

Search for more papers by this author
Gert Muhr

Gert Muhr

Chirurgische Klinik, BG-Kliniken Bergmannsheil, Ruhr-Universität Bochum, Germany

Search for more papers by this author
Dirk Martin

Dirk Martin

Chirurgische Klinik, BG-Kliniken Bergmannsheil, Ruhr-Universität Bochum, Germany

Search for more papers by this author
Matthias Soddemann

Matthias Soddemann

Max-Planck-Institut für molekulare Physiologie, Dortmund, Germany

Search for more papers by this author
Oliver Müller

Corresponding Author

Oliver Müller

Max-Planck-Institut für molekulare Physiologie, Dortmund, Germany

Arbeitsgruppe Tumorgenetik, Max-Planck-Institut für molekulare Physiologie, Otto-Hahn-Strasse 11, D-44227 Dortmund, GermanySearch for more papers by this author
First published: 07 January 2002
Citations: 20

Abstract

A new method for mutation detection is described, which is a technical advancement of the protein truncation test. The new technique is non-radioactive and highly sensitive for detection of virtually all sequence mutations, which lead to a stop signal or to the shift of the translation frame. The method includes four steps: 1) capture of the interesting sequence copies out of the sample by binding to an immobilized complementary sequence, 2) PCR amplification of the gene fragment to be analyzed with primers coding both for amino- and carboxy-terminal tags, 3) in vitro transcription and translation, and 4) analysis of the translation products by Western blot. As an evaluation of the new method, we detected mutated gene copies at a dilution of 1 to 40 compared to the non-mutated gene. Using the method, we were able to detect a mutation in the adenomatous polyposis coli tumor suppressor gene (APC) in a stool sample of a colorectal cancer patient. This mutation could not be detected by direct sequencing of the amplified APC gene fragment. Hum Mutat 19:165–172, 2002. © 2002 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.